中国P站

Gut Microbiome; Intestinal Barrier; Immune Response; Inflammatory Bowel Disease; Autoimmune Diseases; T Cells; Cytokines; Probiotics; Prebiotics; Fecal Microbiota Transplantation

Introduction

The gut microbiome's influence on intestinal health and immune responses is a rapidly evolving area of research. Several studies highlight the interconnectedness of the gut microbiota, intestinal barrier function, and immune cell activity. Sanaullah et al. [1]investigated how gut microbiota and their metabolites regulate intestinal barrier function and T-cell responses in Inflammatory Bowel Disease (IBD), identifying specific bacterial species that modulate T-cell differentiation and epithelial integrity. Shao et al. [2]explored the communication between intestinal epithelial cells and intraepithelial lymphocytes (IELs), emphasizing the importance of this interaction in maintaining intestinal homeostasis and preventing inflammatory diseases. Kim et al. [3]discussed the role of T cell subsets, such as regulatory T cells (Tregs) and Th17 cells, in modulating the intestinal barrier and influencing the gut microbiome composition, including the mechanisms by which these cells maintain immune tolerance. Dietary factors also play a significant role, as highlighted by de Oliveira et al. [4], who examined how specific diets can either promote or prevent intestinal inflammation through their impact on the gut microbiome, epithelial barrier, and mucosal immunity. Chelakkot et al. [5]focused on epithelial barrier dysfunction in the pathogenesis of IBD, specifically investigating how increased intestinal permeability contributes to immune activation and chronic inflammation. Rinninella et al. [6]investigated the mechanisms by which the gut microbiome influences systemic immunity and inflammatory responses, emphasizing the impact of microbial metabolites on immune cell function. Wu et al. [7]reviewed the therapeutic potential of targeting the gut-immune axis in the treatment of autoimmune diseases, exploring the use of probiotics, prebiotics, and Fecal Microbiota Transplantation (FMT) as potential interventions. Mao et al. [8]explored the role of specific cytokines, such as IL-10 and TGF-β, in maintaining intestinal immune homeostasis and promoting epithelial barrier integrity, providing insights into the mechanisms of immune regulation in the gut. Ihekweazu et al. [9]discussed the impact of environmental factors, such as antibiotics and pollutants, on the gut microbiome and intestinal barrier function, exploring how these factors can disrupt the gut-immune axis and contribute to disease. Zhang et al. [10]investigated the use of engineered probiotics to modulate the gut microbiome and enhance intestinal barrier function, exploring the potential of these probiotics to deliver therapeutic molecules and improve gut health.

Description

The intricate relationship between the gut microbiome and the intestinal barrier plays a crucial role in maintaining overall health, particularly in the context of inflammatory and autoimmune conditions. Gut microbiota and their metabolites have been shown to influence intestinal barrier function and T-cell responses, as highlighted in studies on Inflammatory Bowel Disease (IBD) [1]. Specific bacterial species can modulate T-cell differentiation and epithelial integrity, impacting the course of the disease. Understanding these interactions is vital for developing targeted therapeutic strategies.

Intestinal epithelial cells and intraepithelial lymphocytes (IELs) engage in a complex crosstalk that is essential for maintaining intestinal homeostasis [2]. This interaction prevents inflammatory diseases by ensuring the integrity of the intestinal barrier and appropriate immune responses. Disruptions in this communication can lead to increased intestinal permeability and subsequent immune activation, contributing to chronic inflammation. Therefore, preserving this delicate balance is key to preventing intestinal disorders.

T cell subsets, including regulatory T cells (Tregs) and Th17 cells, play a significant role in modulating the intestinal barrier and influencing the gut microbiome composition [3]. These cells maintain immune tolerance and prevent excessive immune responses that could damage the intestinal lining. The mechanisms by which these cells operate are critical for understanding how the immune system regulates the gut environment. Specific cytokines, such as IL-10 and TGF-β, are also involved in maintaining intestinal immune homeostasis and promoting epithelial barrier integrity [8]. These cytokines provide insights into the broader mechanisms of immune regulation within the gut.

Dietary and environmental factors have a profound impact on the gut microbiome and intestinal barrier function [4, 9]. Specific diets can either promote or prevent intestinal inflammation by altering the composition of the gut microbiome, affecting the epithelial barrier, and influencing mucosal immunity. Environmental factors like antibiotics and pollutants can disrupt the gut-immune axis, contributing to disease. The use of engineered probiotics to modulate the gut microbiome and enhance intestinal barrier function represents a promising avenue for improving gut health [10]. These probiotics have the potential to deliver therapeutic molecules and restore balance to the gut microbiome.

Conclusion

The gut microbiome's role in intestinal health and immunity is a complex and actively researched area. Studies show that gut microbiota and their metabolites influence intestinal barrier function and T-cell responses, particularly in inflammatory bowel disease. Specific bacterial species can modulate T-cell differentiation and epithelial integrity. The communication between intestinal epithelial cells and intraepithelial lymphocytes is vital for maintaining intestinal homeostasis and preventing inflammatory diseases. T cell subsets like regulatory T cells and Th17 cells modulate the intestinal barrier and microbiome composition, maintaining immune tolerance. Dietary factors impact the gut microbiome, epithelial barrier, and mucosal immunity, either promoting or preventing intestinal inflammation. Epithelial barrier dysfunction contributes to IBD pathogenesis by increasing intestinal permeability and immune activation. Microbial metabolites influence systemic immunity and inflammatory responses. Targeting the gut-immune axis shows therapeutic potential for autoimmune diseases, with interventions like probiotics, prebiotics, and fecal microbiota transplantation. Specific cytokines like IL-10 and TGF-β maintain intestinal immune homeostasis and epithelial barrier integrity. Environmental factors such as antibiotics and pollutants affect the gut microbiome and intestinal barrier function, potentially disrupting the gut-immune axis. Engineered probiotics are being explored to modulate the gut microbiome, enhance intestinal barrier function, and deliver therapeutic molecules.

References

1. Sanaullah S, Shah K, Tahir A (2023) .Frontiers in Immunology 14:1157169.

   , ,

2. Yuhong S, Astrid SV, Dariush G (2020) .Mucosal Immunology 13:749-761.

   , ,

3. Jin-Man K, Yu-Jin K, Dong-Hyun K (2021) .Gut Microbes 13:1-17.

   , ,

4. Gisele LVdO, Ângela LR, Gisele dSV (2021) .Nutrition Reviews 79:619-637.

   , ,

5. Chelakkot C, Jaehyun G, Seung-Hyun R (2018) .Experimental & Molecular Medicine 50:1-9.

   , ,

6. Erika R, Patrizia R, Michela C (2019) .Microorganisms 7:14.

   , ,

7. Hua W, Carlos AE, Evelyn B (2023) .Nutrients 15:2299.

   , ,

8. Xiaohui M, Ying H, Jian L (2021) .Cytokine & Growth Factor Reviews 61:47-58.

   , ,

9. Fidelma DI, James V (2018) .Cellular and Molecular Gastroenterology and Hepatology 6:159-177.

   , ,

10. Bin Z, Peng W, Jiale S (2023) .Applied Microbiology and Biotechnology 107:5611-5626.

    , ,